Money market account rates today, February 7, 2024 (up to 4.75% APY return)
Money market account rates vary widely. So which banks are offering the best money market account rates today? Find out here.
L'Oreal takes stakes in Chinese, N.American clinics to understand medical aesthetics market
L'Oreal has taken stakes in clinics in China and North America in order to observe and understand the medical aesthetics market, L'Oreal CEO Nicolas Hieronimus said in an earnings call on Friday. The company had announced in August the acquisition of a 10% stake in Swiss skin care firm Galderma. Hieronimus added that L'Oreal would be entering the nutricosmetics market with a new product and said more would be coming.
3 Reasons BMBL is Risky and 1 Stock to Buy Instead
Bumble has been treading water for the past six months, recording a small return of 1.7% while holding steady at $8.20. The stock also fell short of the S&P 500’s 16.8% gain during that period.
3 Reasons to Sell ZUO and 1 Stock to Buy Instead
Zuora trades at $10 per share and has stayed right on track with the overall market, gaining 19.5% over the last six months. At the same time, the S&P 500 has returned 16.9%.
3 Reasons ZM is Risky and 1 Stock to Buy Instead
Zoom has been on fire lately. In the past six months alone, the company’s stock price has rocketed 56%, reaching $86.90 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
3 Reasons to Avoid PANL and 1 Stock to Buy Instead
Over the past six months, Pangaea’s shares (currently trading at $5.34) have posted a disappointing 17.7% loss, well below the S&P 500’s 16.9% gain. This might have investors contemplating their next move.
3 Reasons CRI is Risky and 1 Stock to Buy Instead
Over the past six months, Carter’s stock price fell to $50.45. Shareholders have lost 17.4% of their capital, which is disappointing considering the S&P 500 has climbed by 16.8%. This might have investors contemplating their next move.
3 Reasons to Sell SHOO and 1 Stock to Buy Instead
Over the past six months, Steven Madden’s shares (currently trading at $36.11) have posted a disappointing 14.4% loss, well below the S&P 500’s 16.9% gain. This might have investors contemplating their next move.
3 Reasons UTZ is Risky and 1 Stock to Buy Instead
Utz has gotten torched over the last six months - since August 2024, its stock price has dropped 20.6% to $13.53 per share. This might have investors contemplating their next move.
3 Reasons to Sell SSP and 1 Stock to Buy Instead
What a brutal six months it’s been for E.W. Scripps. The stock has dropped 38.7% and now trades at $1.82, rattling many shareholders. This may have investors wondering how to approach the situation.